Compliance With Dyslipidemia Guidelines in Daily Practice: How Effective Is Cardiovascular Risk Prevention?


GÜNTEKİN Ü., Gumrukcuoglu H. A. , Yaman M., Ozturk F. , Akyol A. , Gumrukcuoglu F. N. , ...Daha Fazla

CLINICAL THERAPEUTICS, cilt.40, ss.2031-2040, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 40 Konu: 12
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.clinthera.2018.10.002
  • Dergi Adı: CLINICAL THERAPEUTICS
  • Sayfa Sayıları: ss.2031-2040

Özet

Purpose: Cardiovascular disease (CVD) due to atherosclerosis is the leading cause of early mortality and morbidity. The current European guidelines on CVD prevention in clinical practice recommend the use of the Systematic Coronary Risk Estimation (SCORE) system. The current American Heart Association guidelines recommend the use of the new pooled cohort risk assessment equations to estimate the 10-year atherosclerotic CVD risk. The purpose of this article was to investigate the compliance of dyslipidemia guidelines in daily practice in patients with dyslipidemia or who have risk factors for CVD.